132 related articles for article (PubMed ID: 1305682)
1. Mechanisms of chemoprotection by oltipraz.
Kensler T; Styczynski P; Groopman J; Helzlsouer K; Curphey T; Maxuitenko Y; Roebuck BD
J Cell Biochem Suppl; 1992; 16I():167-72. PubMed ID: 1305682
[TBL] [Abstract][Full Text] [Related]
2. Oltipraz: clinical opportunities for cancer chemoprevention. p.
Kensler TW; Helzlsouer KJ
J Cell Biochem Suppl; 1995; 22():101-7. PubMed ID: 8538185
[TBL] [Abstract][Full Text] [Related]
3. Cancer chemoprotection by oltipraz: experimental and clinical considerations.
Helzlsouer KJ; Kensler TW
Prev Med; 1993 Sep; 22(5):783-95. PubMed ID: 8234218
[TBL] [Abstract][Full Text] [Related]
4. Oltipraz: a laboratory and clinical review.
Benson AB
J Cell Biochem Suppl; 1993; 17F():278-91. PubMed ID: 8412206
[TBL] [Abstract][Full Text] [Related]
5. Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins.
Kensler TW; Curphey TJ; Maxiutenko Y; Roebuck BD
Drug Metabol Drug Interact; 2000; 17(1-4):3-22. PubMed ID: 11201301
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione.
Kensler TW; Groopman JD; Eaton DL; Curphey TJ; Roebuck BD
Carcinogenesis; 1992 Jan; 13(1):95-100. PubMed ID: 1346373
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD
Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217
[TBL] [Abstract][Full Text] [Related]
8. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones.
Kwak MK; Egner PA; Dolan PM; Ramos-Gomez M; Groopman JD; Itoh K; Yamamoto M; Kensler TW
Mutat Res; 2001 Sep; 480-481():305-15. PubMed ID: 11506823
[TBL] [Abstract][Full Text] [Related]
9. Dithiolethiones for cancer chemoprevention: where do we stand?
Zhang Y; Munday R
Mol Cancer Ther; 2008 Nov; 7(11):3470-9. PubMed ID: 19001432
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention by inducers of carcinogen detoxication enzymes.
Kensler TW
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):965-70. PubMed ID: 9255588
[TBL] [Abstract][Full Text] [Related]
11. Evidence for thiol-dependent production of oxygen radicals by 4-methyl-5-pyrazinyl-3H-1,2-dithiole-3-thione (oltipraz) and 3H-1,2-dithiole-3-thione: possible relevance to the anticarcinogenic properties of 1,2-dithiole-3-thiones.
Kim W; Gates KS
Chem Res Toxicol; 1997 Mar; 10(3):296-301. PubMed ID: 9084909
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships in the induction of Phase II enzymes by derivatives of 3H-1,2-dithiole-3-thione in rats.
Munday R; Zhang Y; Munday CM; Li J
Chem Biol Interact; 2006 Mar; 160(2):115-22. PubMed ID: 16458871
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.
Roebuck BD; Curphey TJ; Li Y; Baumgartner KJ; Bodreddigari S; Yan J; Gange SJ; Kensler TW; Sutter TR
Carcinogenesis; 2003 Dec; 24(12):1919-28. PubMed ID: 14555609
[TBL] [Abstract][Full Text] [Related]
14. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.
O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks
Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750
[TBL] [Abstract][Full Text] [Related]
15. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.
Iida K; Itoh K; Kumagai Y; Oyasu R; Hattori K; Kawai K; Shimazui T; Akaza H; Yamamoto M
Cancer Res; 2004 Sep; 64(18):6424-31. PubMed ID: 15374950
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive activity of oltipraz.
Clapper ML
Pharmacol Ther; 1998 Apr; 78(1):17-27. PubMed ID: 9593327
[TBL] [Abstract][Full Text] [Related]
17. Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice.
Ramos-Gomez M; Dolan PM; Itoh K; Yamamoto M; Kensler TW
Carcinogenesis; 2003 Mar; 24(3):461-7. PubMed ID: 12663505
[TBL] [Abstract][Full Text] [Related]
18. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
Bolton MG; Muñoz A; Jacobson LP; Groopman JD; Maxuitenko YY; Roebuck BD; Kensler TW
Cancer Res; 1993 Aug; 53(15):3499-504. PubMed ID: 8339253
[TBL] [Abstract][Full Text] [Related]
19. Organ-dependent modifying effects of oltipraz on N-nitrosobis(2-oxopropyl)amine (BOP)-initiation of tumorigenesis in hamsters.
Son HY; Nishikawa A; Furukawa F; Kasahara KI; Miyauchi M; Nakamura H; Ikeda T; Hirose M
Cancer Lett; 2000 May; 153(1-2):211-8. PubMed ID: 10779651
[TBL] [Abstract][Full Text] [Related]
20. Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients.
Benson AB; Olopade OI; Ratain MJ; Rademaker A; Mobarhan S; Stucky-Marshall L; French S; Dolan ME
Clin Cancer Res; 2000 Oct; 6(10):3870-7. PubMed ID: 11051232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
